Rosiglitazone Protects Endothelial Cells From Irradiation-Induced Mitochondrial Dysfunction

BACKGROUND AND PURPOSE: Up to 50–60% of all cancer patients receive radiotherapy as part of their treatment strategy. However, the mechanisms accounting for increased vascular risks after irradiation are not completely understood. Mitochondrial dysfunction has been identified as a potential cause of...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Pharmacol
Hlavní autoři: Baselet, Bjorn, Driesen, Ronald B., Coninx, Emma, Belmans, Niels, Sieprath, Tom, Lambrichts, Ivo, De Vos, Winnok H., Baatout, Sarah, Sonveaux, Pierre, Aerts, An
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2020
Témata:
Pharmacology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7082323/
https://ncbi.nlm.nih.gov/pubmed/32231569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.00268
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky